Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING LLC
RANDOX LABORATORIES

Microfluidic Device Could Improve Biomarker Analyses

By Labmedica International staff writers
Posted on 08 Jul 2014
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).
A new microfluidic device could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria.

The physical attributes of cells are important biomarkers in medicine, whether extracting circulating tumor cells from the blood of a cancer patient, or to measure the elasticity of red blood cells due to malaria infection.

Scientists at The Royal Institute of Technology (KTH; Stockholm, Sweden) proposed a microfluidic device that can sort elastic capsules by their deformability. The device consists of a duct embedded with a semi-cylindrical obstacle, and a diffuser which further enhances the sorting capability. The KTH team used extensive computational simulations to model a microfluidic device that would sort cells according to their elasticity. The work draws on numerical techniques and computational capabilities developed in the last decade to handle the complexity of microscale flows.

Most cell sorting techniques rely on the difference between chemical properties of the cells. The problem is chemical properties do not give pathologists the full picture. Two cells can have very similar chemical properties, but different physical properties. Size, shape and elasticity, or deformability, are important attributes that can be also enable cell sorting, given the right kind of device.

The scientists demonstrated that the device can operate reasonably well under changes in the initial position of the capsule. The efficiency of the device remains essentially unaltered under small changes of the obstacle shape from semicircular to semi-elliptic cross-section. Confinement along the direction perpendicular to the plane of the device increases its efficiency. This work is the first numerical study of cell sorting by a realistic microfluidic device.

Dhrubaditya Mitra, PhD, an assistant professor in theoretical physics and a coauthor of the study offers an example of why elasticity matters. “If you are infected with malaria, the physical nature of your red blood cells changes. They become harder and red blood cells also become harder as they get older too. These harder red blood cells are filtered by the spleen which acts like a sieve. The softer red blood cells can squeeze through the gaps but the harder ones cannot.” The study was published on June 20, 2014, in the journal Soft Matter.

Related Links:

The Royal Institute of Technology



MEDLAB Asia
KARL HECHT GMBH & CO KG
CELLAVISION AB

Channels

Genetic Tests

view channel
Image: For each chromosome, key SNPs are displayed above the chromosome and non-key SNPs below the chromosome, enabling users to determine the accuracy of haploblock calling. SNPs failed to be called are displayed as white points in the middle of the chromosome (Photo courtesy of Illumina).

Karyomapping Proposed as Alternative to Preimplantation Genetic Diagnosis for Evaluation of IVF Embryos

British researchers have suggested that karyomapping is a viable and cost-effective method for detecting a wide range of genetic diseases in IVF (in vitro fertilization) embryos. Preimplantation Genetic... Read more

Industry News

view channel
Image: Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay, a companion diagnostic immunohistochemical test in the final stages of the FDA premarket approval process (Photo courtesy of Ventana Medical Systems and PRNewsFoto).

Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients

Ventana Medical Systems, Inc. (Tucson, AZ, USA) has announced its US Food & Drug Administration (FDA) final stage submission for premarket approval (PMA) of its companion diagnostic (CDx) immunohistochemistry... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
18 Mar 2015 - 20 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.